BioBusiness 2012 - The leading high-level BioPharma strategy and bio-partnering conference

What attendees said about BioBusiness 2012

"Audience interaction was great – like the debate!" - Carole Nuechterlein, Head, Roche Venture Fund

"Small meeting with opportunity to meet others informally" – Rob Pinnock, MSD

"Location and senior level attendees" - Malcolm Bates, Taylor Wessing LLP

"Gain insight from investors, big pharma and biotech peers. Meet potential partners. Difference is intimacy" – Rob Grundy, Almac Discovery Ltd

"Quality of attendees, timing, difference to other meetings." - N.J McWilliam, Flamel Technologies

BioBusiness - the leading bio-partnering life science conference which places strategy at its core

BioBusiness 2013 will be the only place in London where senior professionals, VP to CEO level delegates from small biotech's through to top 10 pharma's and key financers and advisors behind innovation will gather to discuss high level strategy and build quality relationships. This event is where forward thinking companies will come to make their next big deal.

Why BioBusiness is Different from other European bio-partnering conferences

BioBusiness isn't your typical frenzied partnering meeting with a huge exhibition, covering everything under the sun; only the most pertinent issues having an impact on your strategies will be discussed. Most importantly, the real decision makers will be there, and you'll have quality, face-to-face time with people that matter.